Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients

Publication Date: December 1, 2015

Last Updated: March 14, 2022

Recommendations

Hospitalized Adult and Pediatric Patients Without Cystic Fibrosis

Recombinant human dornase alfa should not be used in adults and children with non-CF bronchiectasis.
Routine use of bronchodilators to aid in secretion clearance is not recommended.
Routine use of aerosolized N-acetylcysteine to improve airway clearance is not recommended.

6731

Overview

Title

Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients

Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients

Recommendations

Hospitalized Adult and Pediatric Patients Without Cystic Fibrosis

Overview

Title

Authoring Organization